Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × adavosertib × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 5 Fallopian Tube Neoplasms 3 Uterine Cervical Neoplasms 2 Vaginal Neoplasms 1 Uterine Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation 1 Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Endometrioid 1 Carcinoma 1 Brenner Tumor 1

Interventions

Paclitaxel 109 Carboplatin 107 Cisplatin 43 Topotecan 38 Cyclophosphamide 28 Gemcitabine 27 Docetaxel 25 liposomal doxorubicin 24 Bevacizumab 24 pembrolizumab 19 Peripheral Blood Stem Cell Transplantation 17 Filgrastim 17 Taxes 14 Drug Therapy 12 sargramostim 11 Hyperthermic Intraperitoneal Chemotherapy 11 Chemotherapy, Adjuvant 11 olaparib 10 Surgical Procedures, Operative 10 Immunohistochemistry 10 Therapeutics 9 Etoposide 9 mirvetuximab soravtansine 8 Nivolumab 8 Flow Cytometry 8 Amifostine 8 oregovomab 7 Psychiatric Rehabilitation 7 Melphalan 7 Erlotinib Hydrochloride 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01164995 2023-09-07

M10MKO

The Netherlands Cancer Institute

Phase 2 Completed

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡